N-1-tert-butyl-substituted quinolones: In vitro anti-Mycobacterium avium activities and structure-activity relationship studies

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2637-2643

  Klopman, Gilles ^a   Fercu, Dan ^a   Renau, Thomas E ^b   Jacobs, Michael R ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PAZUFLOXACIN; PD 138926; PD 158804; PD 161314; PD 161315; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TOSUFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0029981122     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2637     Document Type: Article

References (22)

1. Chu, D. T. W., and P. B. Fernandes. 1991. Recent developments in the field of quinolone antibacterial agents. Adv. Drug Res. 21:39-144.
2. Domagala, J. M. 1994. Structure-activity and structure-side-effect relationships for quinolone antibacterials. J. Antimicrob. Chemother. 33:685-706.
3. Domagala, J. M., A. J. Bridges, T. P. Culbertson, L. Gambino, S. E. Hagen, G. Karrick, K. Porter, J. P. Sanchez, J. A. Sesnie, F. G. Spense, D. Szotek, and J. Wemple. 1991. Synthesis and biological activity of 5-amino and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship. J. Med. Chem. 34: 1142-1154.
4. Domagala, J. M., S. E. Hagen, T. Joannides, J. S. Kiely, E. Labordo, and M. C. Schroeder. 1993. Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1-pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy. J. Med. Chem. 36:871-882.
5. Domagala, J. M., L. D. Hanna, C. L. Heifetz, M. P. Hutt, T. F. Mich, J. P. Sanchez, and M. Solomon. 1986. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J. Med. Chem. 29:394-404.
6. Domagala, J. M., C. L. Heifetz, M. P. Hutt, T. F. Mich, J. B. Nichols, M. Solomon, and D. F. Worth. 1988. 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydto-4-oxo-3- quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials. J. Med. Chem. 31:991-1001.
7. Hagen, S. E., J. M. Domagala, C. L. Heifetz, and J. Johnson. 1991. Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids. J. Med. Chem. 34:1155-1161.
8. Hagen, S. E., J. M. Domagala, C. L. Heifetz, J. P. Sanchez, and M. Solomon. 1990. New quinolone antibacterial agents. Synthesis and biological activity of 7-(3,3- or 3,4-disubstituted-1-pyrrolidyl)quinoline-3-carboxylic acid. J. Med. Chem. 33:849-854.
9. Klopman, G. 1984. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Am. Chem. Soc. 106:7315-7321.
10. Klopman, G. 1992. MULTICASE: a hierarchical computer automated structure evaluation program. Quant. Struct.-Act. Relat. 11:176-184.
11. Klopman, G., D. Fercu, J.-Y. Li, H. S. Rosenkranz, and M. R. Jacobs. 1996. Antimycobacterial quinolones: a comparative analysis of structure-activity and structure-cytotoxicity relationships. Res. Microbiol. 147:86-96.
12. Klopman, G., J.-Y. Li, S. Wang, A. J. Pearson, K. Chang, M. R. Jacobs, S. Bajaksouzian, and J. J. Elmer. 1994. In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations. Antimicrob. Agents Chemother. 38:1794-1802.
13. Klopman, G., O. T. Macina, M. E. Levinson, and H. S. Rosenkranz. 1987. Computer automated structure evaluation of quinolone antibacterial agents. Antimicrob. Agents Chemother. 31:1831-1840.
14. Klopman, G., S. Wang, M. R. Jacobs, S. Bajaksouzian, K. Edmonds, and J. J. Ellner. 1993. Anti-Mycobacterium avium activity of quinolones: in vitro activities. Antimicrob. Agents Chemother. 37:1799-1806.
15. Klopman, G., S. Wang, M. R. Jacobs, and J. J. Ellner. 1993. Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies. Antimicrob. Agents Chemother. 37:1807-1815.
16. Leysen, D. C., A. Haemers, and S. R. Pattyn. 1989. Mycobacteria and the new quinolones. Antimicrob. Agents Chemother. 33:1-5.
17. Nikaido, H., and D. G. Thanassi. 1993. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37:1393-1399.
18. Renau, T. E., J. P. Sanchez, J. W. Gage, J. A. Denver, M. A. Shapiro, S. J. Gracheck, and J. M. Domagala. 1996. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7. J. Med. Chem. 39:729-735.
19. Renau, T. E., J. P. Sanchez, M. A. Shapiro, J. A. Dever, S. J. Gracheck, and J. M. Domagala. 1995. Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria. J. Med. Chem. 38:2974-2977.
20. Shen, L. L. 1994. Molecular mechanisms of DNA gyrase inhibition by quinolone antibacterials. Adv. Pharmacol. 29A:285-304.
21. Tullman, R. H., and R. P. Hanzlik. 1984. Inactivation of cytochrome P-450 and monoamine oxidase by cyclopropylamine. Drug Metab. Rev. 15:1163-1182.
22. Yajko, D. M., P. S. Nassos, and W. K. Hadley. 1987. Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. Antimicrob. Agents Chemother. 31:1579-1584.